Quantcast

Treating A Common Skin Disorder

December 13, 2010

(Ivanhoe Newswire) — Targeting blood vessel growth is shown to treat psoriasis, a common skin disorder.

Psoriasis is a common skin disorder that arises when immune cells become overactive and generate unneeded inflammatory responses in the skin. Dysregulated growth of new blood vessels from pre-existing vessels (a process known as angiogenesis) is one hallmark of psoriasis, which is also characterized by thick silvery scales on affected areas of skin and itchy, dry, red patches.

A team of researchers, led by Michael Schön, at Georg August University, Germany, has now found that reducing angiogenesis in xenotransplantation models of psoriasis and in mice with a disease that resembles psoriasis alleviates disease. They suggest that their non-viral gene therapy approach to reducing angiogenesis might provide a new approach to treating psoriasis and, perhaps, other inflammatory skin disorders characterized by dysregulated angiogenesis.

SOURCE: JCI, published online December 6, 2010




comments powered by Disqus